Autoimmune hepatitis can be effectively controlled by standardized treatment, but it is often difficult to cure. Autoimmune hepatitis is a liver disease caused by autoimmune factors, leading to abnormal inflammatory lesions caused by liver damage, which can lead to symptoms such as weakness, abnormal appetite and abdominal distension. For patients suffering from autoimmune hepatitis, timely acceptance of standardized treatment can allow individuals to effectively control their condition and prevent liver failure. The patient can follow the doctor’s instructions to use to the appropriate drugs for treatment, such as tacrolimus, azathioprine and other immunosuppressive drugs, as well as methylprednisolone, prednisone and other glucocorticosteroids, the specific use of the drug program to comply with the doctor’s instructions. For the vast majority of patients, the individual’s condition can be controlled with treatment, effectively improving the individual’s quality of life. However, the prognosis for a small number of outbreaks, even after treatment, is poor, and the possibility of short-term mortality cannot be ruled out. Individuals diagnosed with autoimmune hepatitis should cooperate with treatment.